TY - JOUR AU - Wedemeyer, H. AU - Dore, G. J. AU - Ward, J. W. PY - 2015 DA - 2015// TI - Estimates on HCV disease burden worldwide - filling the gaps JO - J Viral Hepat VL - 22 UR - https://doi.org/10.1111/jvh.12371 DO - 10.1111/jvh.12371 ID - Wedemeyer2015 ER - TY - JOUR AU - Ghany, M. G. AU - Strader, D. B. AU - Thomas, D. L. AU - Seeff, L. B. PY - 2009 DA - 2009// TI - Diagnosis, management, and treatment of hepatitis C: an update JO - Hepatology (Baltimore, Md) VL - 49 UR - https://doi.org/10.1002/hep.22759 DO - 10.1002/hep.22759 ID - Ghany2009 ER - TY - JOUR AU - Zimmermann, H. W. AU - Tacke, F. PY - 2013 DA - 2013// TI - Sofosbuvir for hepatitis C - is brevity the soul of wit? JO - Zeitschrift fur Gastroenterologie VL - 51 UR - https://doi.org/10.1055/s-0033-1335978 DO - 10.1055/s-0033-1335978 ID - Zimmermann2013 ER - TY - JOUR PY - 2015 DA - 2015// TI - Recommendations on Treatment of Hepatitis C 2015 JO - J Hepatol VL - 63 UR - https://doi.org/10.1016/j.jhep.2015.03.025 DO - 10.1016/j.jhep.2015.03.025 ID - ref4 ER - TY - JOUR AU - Kim, D. D. AU - Hutton, D. W. AU - Raouf, A. A. PY - 2015 DA - 2015// TI - Cost-effectiveness model for hepatitis C screening and treatment: Implications for Egypt and other countries with high prevalence JO - Glob Public Health VL - 10 UR - https://doi.org/10.1080/17441692.2014.984742 DO - 10.1080/17441692.2014.984742 ID - Kim2015 ER - TY - JOUR AU - Camma, C. AU - Petta, S. AU - Enea, M. PY - 2012 DA - 2012// TI - Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C JO - Hepatology (Baltimore, Md) VL - 56 UR - https://doi.org/10.1002/hep.25734 DO - 10.1002/hep.25734 ID - Camma2012 ER - TY - JOUR AU - Falleti, E. AU - Cmet, S. AU - Fabris, C. PY - 2013 DA - 2013// TI - Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naive patients with chronic hepatitis C JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0080764 DO - 10.1371/journal.pone.0080764 ID - Falleti2013 ER - TY - JOUR AU - Asselah, T. AU - Estrabaud, E. AU - Bieche, I. PY - 2010 DA - 2010// TI - Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin JO - Liver Int VL - 30 UR - https://doi.org/10.1111/j.1478-3231.2010.02283.x DO - 10.1111/j.1478-3231.2010.02283.x ID - Asselah2010 ER - TY - JOUR AU - Maekawa, S. AU - Sakamoto, M. AU - Miura, M. PY - 2012 DA - 2012// TI - Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection JO - Hepatology (Baltimore, Md) VL - 56 UR - https://doi.org/10.1002/hep.25826 DO - 10.1002/hep.25826 ID - Maekawa2012 ER - TY - JOUR AU - Garcia-Martin, E. AU - Agundez, J. A. AU - Maestro, M. L. PY - 2013 DA - 2013// TI - Influence of vitamin D-related gene polymorphisms (CYP27B and VDR) on the response to interferon/ribavirin therapy in chronic hepatitis C JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0074764 DO - 10.1371/journal.pone.0074764 ID - Garcia-Martin2013 ER - TY - JOUR AU - White, J. H. PY - 2012 DA - 2012// TI - Vitamin D, metabolism and signaling in the immune system JO - Rev Endocr Metab Disord VL - 13 UR - https://doi.org/10.1007/s11154-011-9195-z DO - 10.1007/s11154-011-9195-z ID - White2012 ER - TY - JOUR AU - Miroliaee, A. AU - Nasiri-Toosi, M. AU - Khalilzadeh, O. AU - Esteghamati, A. AU - Abdollahi, A. AU - Mazloumi, M. PY - 2010 DA - 2010// TI - Disturbances of parathyroid hormone-vitamin D axis in non-cholestatic chronic liver disease: a cross-sectional study JO - Hepatol Int VL - 4 UR - https://doi.org/10.1007/s12072-010-9194-2 DO - 10.1007/s12072-010-9194-2 ID - Miroliaee2010 ER - TY - JOUR AU - Bitetto, D. AU - Fattovich, G. AU - Fabris, C. PY - 2011 DA - 2011// TI - Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C JO - Hepatology (Baltimore, Md) VL - 53 UR - https://doi.org/10.1002/hep.24201 DO - 10.1002/hep.24201 ID - Bitetto2011 ER - TY - JOUR AU - Kitson, M. T. AU - Dore, G. J. AU - George, J. PY - 2013 DA - 2013// TI - Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection JO - J Hepatol VL - 58 UR - https://doi.org/10.1016/j.jhep.2012.11.017 DO - 10.1016/j.jhep.2012.11.017 ID - Kitson2013 ER - TY - JOUR AU - Holick, M. F. PY - 2011 DA - 2011// TI - Vitamin D: evolutionary, physiological and health perspectives JO - Curr Drug Targets VL - 12 UR - https://doi.org/10.2174/138945011793591635 DO - 10.2174/138945011793591635 ID - Holick2011 ER - TY - JOUR AU - Rosen, C. J. AU - Adams, J. S. AU - Bikle, D. D. PY - 2012 DA - 2012// TI - The nonskeletal effects of vitamin D: an Endocrine Society scientific statement JO - Endocr Rev VL - 33 UR - https://doi.org/10.1210/er.2012-1000 DO - 10.1210/er.2012-1000 ID - Rosen2012 ER - TY - JOUR AU - Lange, C. M. AU - Gouttenoire, J. AU - Duong, F. H. AU - Morikawa, K. AU - Heim, M. H. AU - Moradpour, D. PY - 2014 DA - 2014// TI - Vitamin D receptor and Jak-STAT signaling crosstalk results in calcitriol-mediated increase of hepatocellular response to IFN-alpha JO - J Immunol (Baltimore, Md : 1950) VL - 192 UR - https://doi.org/10.4049/jimmunol.1302296 DO - 10.4049/jimmunol.1302296 ID - Lange2014 ER - TY - JOUR AU - Feld, J. J. AU - Hoofnagle, J. H. PY - 2005 DA - 2005// TI - Mechanism of action of interferon and ribavirin in treatment of hepatitis C JO - Nature VL - 436 UR - https://doi.org/10.1038/nature04082 DO - 10.1038/nature04082 ID - Feld2005 ER - TY - JOUR AU - Su, X. AU - Yee, L. J. AU - Im, K. PY - 2008 DA - 2008// TI - Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C JO - J Hepatol VL - 49 UR - https://doi.org/10.1016/j.jhep.2008.04.011 DO - 10.1016/j.jhep.2008.04.011 ID - Su2008 ER - TY - JOUR AU - Welzel, T. M. AU - Morgan, T. R. AU - Bonkovsky, H. L. PY - 2009 DA - 2009// TI - Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial JO - Hepatology (Baltimore, Md) VL - 49 UR - https://doi.org/10.1002/hep.22877 DO - 10.1002/hep.22877 ID - Welzel2009 ER - TY - JOUR AU - Holmes, J. A. AU - Congiu, M. AU - Bonanzinga, S. PY - 2015 DA - 2015// TI - The relationships between IFNL4 genotype, intrahepatic interferon-stimulated gene expression and interferon treatment response differs in HCV-1 compared with HCV-3 JO - Aliment Pharmacol Ther VL - 42 UR - https://doi.org/10.1111/apt.13263 DO - 10.1111/apt.13263 ID - Holmes2015 ER - TY - JOUR PY - 2011 DA - 2011// TI - Clinical Practice Guidelines: management of hepatitis C virus infection JO - J Hepatol VL - 55 UR - https://doi.org/10.1016/j.jhep.2011.02.023 DO - 10.1016/j.jhep.2011.02.023 ID - ref22 ER - TY - STD TI - Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology (Baltimore, Md). 1994; 20(1 Pt 1):15–20. Epub 1994/07/01. eng. ID - ref23 ER - TY - JOUR AU - Heid, C. A. AU - Stevens, J. AU - Livak, K. J. AU - Williams, P. M. PY - 1996 DA - 1996// TI - Real time quantitative PCR JO - Genome Res VL - 6 UR - https://doi.org/10.1101/gr.6.10.986 DO - 10.1101/gr.6.10.986 ID - Heid1996 ER - TY - JOUR AU - Witthoft, T. AU - Moller, B. AU - Wiedmann, K. H. PY - 2007 DA - 2007// TI - Safety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial JO - J Viral Hepat VL - 14 UR - https://doi.org/10.1111/j.1365-2893.2007.00871.x DO - 10.1111/j.1365-2893.2007.00871.x ID - Witthoft2007 ER - TY - JOUR AU - Ladero, J. M. AU - Martin, E. G. AU - Fernandez, C. PY - 2012 DA - 2012// TI - Predicting response to therapy in chronic hepatitis C: an approach combining interleukin-28B gene polymorphisms and clinical data JO - J Gastroenterol Hepatol VL - 27 UR - https://doi.org/10.1111/j.1440-1746.2011.06834.x DO - 10.1111/j.1440-1746.2011.06834.x ID - Ladero2012 ER - TY - JOUR AU - Matthews, D. R. AU - Hosker, J. P. AU - Rudenski, A. S. AU - Naylor, B. A. AU - Treacher, D. F. AU - Turner, R. C. PY - 1985 DA - 1985// TI - Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man JO - Diabetologia VL - 28 UR - https://doi.org/10.1007/BF00280883 DO - 10.1007/BF00280883 ID - Matthews1985 ER - TY - JOUR AU - Hezode, C. PY - 2012 DA - 2012// TI - Boceprevir and telaprevir for the treatment of chronic hepatitis C: safety management in clinical practice JO - Liver Int VL - 32 UR - https://doi.org/10.1111/j.1478-3231.2011.02707.x DO - 10.1111/j.1478-3231.2011.02707.x ID - Hezode2012 ER - TY - JOUR AU - Poveda, E. AU - Wyles, D. L. AU - Mena, A. AU - Pedreira, J. D. AU - Castro-Iglesias, A. AU - Cachay, E. PY - 2014 DA - 2014// TI - Update on hepatitis C virus resistance to direct-acting antiviral agents JO - Antiviral Res VL - 108 UR - https://doi.org/10.1016/j.antiviral.2014.05.015 DO - 10.1016/j.antiviral.2014.05.015 ID - Poveda2014 ER - TY - JOUR AU - Vidal-Castineira, J. R. AU - Lopez-Vazquez, A. AU - Alonso-Arias, R. PY - 2012 DA - 2012// TI - A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping JO - J Hepatol VL - 56 UR - https://doi.org/10.1016/j.jhep.2012.01.011 DO - 10.1016/j.jhep.2012.01.011 ID - Vidal-Castineira2012 ER - TY - JOUR AU - Nimer, A. AU - Mouch, A. PY - 2012 DA - 2012// TI - Vitamin D improves viral response in hepatitis C genotype 2-3 naive patients JO - World J Gastroenterol VL - 18 UR - https://doi.org/10.3748/wjg.v18.i8.800 DO - 10.3748/wjg.v18.i8.800 ID - Nimer2012 ER - TY - JOUR AU - Wang, T. J. AU - Zhang, F. AU - Richards, J. B. PY - 2010 DA - 2010// TI - Common genetic determinants of vitamin D insufficiency: a genome-wide association study JO - Lancet VL - 376 UR - https://doi.org/10.1016/S0140-6736(10)60588-0 DO - 10.1016/S0140-6736(10)60588-0 ID - Wang2010 ER - TY - JOUR AU - Villar, L. M. AU - Campo, J. A. AU - Ranchal, I. AU - Lampe, E. AU - Romero-Gomez, M. PY - 2013 DA - 2013// TI - Association between vitamin D and hepatitis C virus infection: a meta-analysis JO - World J Gastroenterol VL - 19 UR - https://doi.org/10.3748/wjg.v19.i35.5917 DO - 10.3748/wjg.v19.i35.5917 ID - Villar2013 ER - TY - STD TI - Fernandez Fernandez N, Linares Torres P, Joao Matias D, Jorquera Plaza F, Olcoz Goni JL. [Vitamin D deficiency in chronic liver disease, clinical-epidemiological analysis and report after vitamin d supplementation]. Gastroenterologia y hepatologia. 2015 Nov 16. Epub 2015/11/26. Deficit de vitamina D en la enfermedad hepatica cronica, analisis clinico epidemiologico y tras aporte vitaminico. Spa. ID - ref34 ER - TY - JOUR AU - Finkelmeier, F. AU - Kronenberger, B. AU - Zeuzem, S. AU - Piiper, A. AU - Waidmann, O. PY - 2015 DA - 2015// TI - Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0132119 DO - 10.1371/journal.pone.0132119 ID - Finkelmeier2015 ER - TY - JOUR AU - Tacke, F. AU - Trautwein, C. PY - 2015 DA - 2015// TI - Mechanisms of liver fibrosis resolution JO - J Hepatol VL - 63 UR - https://doi.org/10.1016/j.jhep.2015.03.039 DO - 10.1016/j.jhep.2015.03.039 ID - Tacke2015 ER - TY - JOUR AU - Cheng, J. B. AU - Levine, M. A. AU - Bell, N. H. AU - Mangelsdorf, D. J. AU - Russell, D. W. PY - 2004 DA - 2004// TI - Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase JO - Proc Natl Acad Sci U S A VL - 101 UR - https://doi.org/10.1073/pnas.0402490101 DO - 10.1073/pnas.0402490101 ID - Cheng2004 ER - TY - JOUR AU - Nissen, J. AU - Rasmussen, L. B. AU - Ravn-Haren, G. PY - 2014 DA - 2014// TI - Common variants in CYP2R1 and GC genes predict vitamin D concentrations in healthy Danish children and adults JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0089907 DO - 10.1371/journal.pone.0089907 ID - Nissen2014 ER - TY - JOUR AU - Baur, K. AU - Mertens, J. C. AU - Schmitt, J. PY - 2012 DA - 2012// TI - The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patients JO - Antivir Ther VL - 17 UR - https://doi.org/10.3851/IMP2018 DO - 10.3851/IMP2018 ID - Baur2012 ER - TY - JOUR AU - Khairy, M. AU - Fouad, R. AU - Mabrouk, M. PY - 2013 DA - 2013// TI - The impact of interleukin 28b gene polymorphism on the virological response to combined pegylated interferon and ribavirin therapy in chronic HCV genotype 4 infected egyptian patients using data mining analysis JO - Hepat Mon VL - 13 ID - Khairy2013 ER - TY - JOUR AU - Youssef, S. S. AU - Abbas, E. A. AU - Abd-el-Aal, A. M. AU - Omran, M. H. AU - Barakat, A. AU - Seif, S. M. PY - 2014 DA - 2014// TI - IL28B rs 12979860 predicts response to treatment in Egyptian hepatitis C virus genotype 4 patients and alpha fetoprotein increases its predictive strength JO - J Interferon Cytokine Res VL - 34 UR - https://doi.org/10.1089/jir.2013.0115 DO - 10.1089/jir.2013.0115 ID - Youssef2014 ER - TY - JOUR AU - Tsamandas, A. C. AU - Syrokosta, I. AU - Thomopoulos, K. PY - 2006 DA - 2006// TI - Potential role of hepatic progenitor cells expression in cases of chronic hepatitis C and their relation to response to therapy: a clinicopathologic study JO - Liver Int VL - 26 UR - https://doi.org/10.1111/j.1478-3231.2006.01306.x DO - 10.1111/j.1478-3231.2006.01306.x ID - Tsamandas2006 ER - TY - JOUR AU - Abdoul, H. AU - Mallet, V. AU - Pol, S. AU - Fontanet, A. PY - 2008 DA - 2008// TI - Serum alpha-fetoprotein predicts treatment outcome in chronic hepatitis C patients regardless of HCV genotype JO - PLoS One VL - 3 UR - https://doi.org/10.1371/journal.pone.0002391 DO - 10.1371/journal.pone.0002391 ID - Abdoul2008 ER - TY - JOUR AU - Degasperi, E. AU - Valenti, L. AU - Aghemo, A. PY - 2014 DA - 2014// TI - Interleukin 28B genotype and insulin resistance in chronic hepatitis C patients JO - Antivir Ther VL - 19 UR - https://doi.org/10.3851/IMP2743 DO - 10.3851/IMP2743 ID - Degasperi2014 ER - TY - JOUR AU - Vukovic, V. R. AU - Baskic, D. AU - Mijailovic, Z. PY - 2015 DA - 2015// TI - Association between risk factors, basal viral load, virus genotype and the degree of liver fibrosis with the response to the therapy in patients with chronic hepatitis C virus infection JO - Vojnosanit Pregl VL - 72 UR - https://doi.org/10.2298/VSP1506505V DO - 10.2298/VSP1506505V ID - Vukovic2015 ER -